СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA

Código QR

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA

Abstract. A study was carried out in hundred-five patients with severe or mid-severe clinical courseof community-acquired pneumonia. Clinical observations showed that introduction of Imunofan andPolyoxidonium within combined therapeutic regimen administered to the patients, exerts a pronounced posit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	L. R. Mukhamadieva, G. A. Mavzyutova, R. M. Fazlyeva, N. R. Bikhmetova
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2014
Materias:	community-acquired pneumonia imunofan polyoxidonium Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/0b95757e18124d97a8fecf549c4cabcb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PATTERN OF LOCAL IMMUNE ALTERATIONS IN THE PATIENTS WITH CHRONIC ADENOIDITIS, AND AN OPPORTUNITY OF THEIR CORRECTION WITH IMUNOFAN
por: R. N. Kuznetsova, et al.
Publicado: (2014)

Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients
por: Ugajin M, et al.
Publicado: (2014)

FEATURES OF IMMUNE DISTURBANCES IN COMMUNITY-ACQUIRED PNEUMONIAS
por: G. A. Mavziutova, et al.
Publicado: (2014)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
por: L. A. Demidchik, et al.
Publicado: (2016)

Assessing the Impact of Gender and COPD on the Incidence and Mortality of Hospital-Acquired Pneumonia. A Retrospective Cohort Study Using the Spanish National Discharge Database (2016–2019)
por: Javier de-Miguel-Diez, et al.
Publicado: (2021)

The COVID-19 Pandemic and the Incidence of the Non-COVID-19 Pneumonia in Adults
por: Chienhsiu Huang
Publicado: (2021)

Clinical and laboratory findings in elderly with Community-Acquired Pneumonia in Babol, northern Iran – 2017-2019
por: Habibi Saleh, et al.
Publicado: (2021)

Role of blood urea nitrogen and serum albumin ratio in predicting severity of community acquired pneumonia (CAP)
por: Mehul Agarwal, et al.
Publicado: (2021)

Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens
por: Trudy H. Grossman, et al.
Publicado: (2017)

Cell population data in identifying active tuberculosis and community-acquired pneumonia
por: Sun Tingting, et al.
Publicado: (2021)

Evaluation of severity scoring systems in patients with severe community acquired pneumonia
por: Spasovska Katerina, et al.
Publicado: (2021)

Associations of Serum Resistin With the Severity and Prognosis in Patients With Community-Acquired Pneumonia
por: Chun-Mei Feng, et al.
Publicado: (2021)

Comparative effect of immunomodulators on the contents of hydrolase inhibitors and lactoferrin in community-acquired pneumonia in adults
por: M. P. Kostinov, et al.
Publicado: (2020)

Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors
por: Chen H, et al.
Publicado: (2020)

An Early Screening Tool for Discharge Planning Shortened Length of Hospital Stay for Elderly Patients with Community-Acquired Pneumonia
por: Chen H, et al.
Publicado: (2021)

Association of Admission Blood Glucose Level with All-Cause Mortality According to Age in Patients with Community Acquired Pneumonia
por: Shen Y, et al.
Publicado: (2021)

Community-Acquired Pneumonia among Patients with COPD in Spain from 2016 to 2019. Cohort Study Assessing Sex Differences in the Incidence and Outcomes Using Hospital Discharge Data
por: Javier de Miguel-Diez, et al.
Publicado: (2021)

Clinical features of pneumonia with adverse outcome (based on materials of the therapeutic department of the Angapov Republican Clinical Emergency Hospital, Ulan-Ude for 2013-2015)
por: E. V. Bashkueva, et al.
Publicado: (2017)

Community-Acquired Respiratory Distress Syndrome Toxin: Unique Exotoxin for M. pneumoniae
por: Xiaoling Su, et al.
Publicado: (2021)

Mycoplasma Pneumoniae and Bronchial Asthma in Children
por: hala Elzawawy, et al.
Publicado: (2020)

SPECTRUM OF CULTURE POSITIVE HOSPITAL ACQUIRED PNEUMONIA IN PATIENTS RECEIVING PROTON PUMP INHIBITORS
por: Aaqib Jahangir Khan, et al.
Publicado: (2018)

The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population
por: Ma CM, et al.
Publicado: (2021)

Identified micro-organisms in hospitalized community-acquired pneumonia patients living near goat and poultry farms
por: Inge Roof, et al.
Publicado: (2021)

In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study
por: Yukiyo Sakamoto, et al.
Publicado: (2021)

Method of quality improvement and economic efficiency of pharmacotherapy for community-acquired pneumonia and its utility in Ukraine health-care facilities
por: A.B. Zimenkovsky
Publicado: (2020)

COMMUNITY-ACQUIRED PNEUMONIA PNEUMOCOCCAL ETIOLOGY AND MICROBIOLOGICAL ASPECTS OF NASOPHARYNGEAL CARRIAGE IN CHILDREN IN THE REPUBLIC OF TATARSTAN
por: L. T. Bayazitova, et al.
Publicado: (2017)

Study on inflammatory factors and curative effect of Rhizoma Imperata on community acquired pneumonia based on TLR4/NF-κB signaling pathway
por: Qiu-Cheng Li, et al.
Publicado: (2021)

Serum interleukin-17 predicts severity and prognosis in patients with community acquired pneumonia: a prospective cohort study
por: Chun-Mei Feng, et al.
Publicado: (2021)

Age, Pulse, Urea and Albumin (APUA) Model: A Tool for Predicting in-Hospital Mortality of Community-Acquired Pneumonia Adapted for Patients with Type 2 Diabetes
por: Ma CM, et al.
Publicado: (2020)

Fall of Community-Acquired Pneumonia in Children following COVID-19 Non-Pharmaceutical Interventions: A Time Series Analysis
por: Alexis Rybak, et al.
Publicado: (2021)

IL-8 CHEMOTACTIC FACTOR IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AND FEATURES OF IL-8 GENE POLYMORPHISM (251 T/А)
por: L. F. Aznabaeva, et al.
Publicado: (2014)

Prevención y tratamiento de la neumonía adquirida en la comunidad en pacientes adultos: Un enfoque para la atención primaria
por: FICA C.,ALBERTO
Publicado: (2002)

Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature
por: Konstantinos G. Kyriakoulis, et al.
Publicado: (2021)

Diseño de un índice pronóstico clínico para el manejo de la neumonía del adulto adquirida en la comunidad
por: Saldías P,Fernando, et al.
Publicado: (2004)

Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT
por: Sam Barratt, et al.
Publicado: (2021)

Effect of adjunctive single high-dose vitamin D3 on outcome of community-acquired pneumonia in hospitalised adults: The VIDCAPS randomised controlled trial
por: Sandy Slow, et al.
Publicado: (2018)

Características clínicas de la neumonía adquirida en la comunidad del adulto inmunocompetente hospitalizado según el agente causal
por: Saldias Peñafiel,Fernando, et al.
Publicado: (2018)

Predictores clínicos de bacteriemia en adultos inmunocompetentes hospitalizados por neumonía adquirida en la comunidad
por: Saldías P,Fernando, et al.
Publicado: (2015)

An unusual non-resolving community-acquired pneumonia
por: Andrea Zappalà, et al.
Publicado: (2021)

Сlinical case of focal alopecia in a child with atopy
por: A. A. Barilo, et al.
Publicado: (2021)